Authors
Stephan A. Müller
Oliver Preische
Hamid R. Sohrabi, Edith Cowan UniversityFollow
Susanne Gräber
Mathias Jucker
Janko Dietzsch
John M. Ringman
Ralph Martins, Edith Cowan UniversityFollow
Eric M. McDade
Peter R. Schofield
Bernardino F. Ghetti
Martin N. Rossor
Neill R. Graff-Radford
Johannes Levin
Douglas R. Galasko
Kimberly A. Quaid
Stephen P. Salloway
Chengjie Xiong
Tammie L. Benzinger
Virginia D. Buckles
C. L. Masters
Reisa A. Sperling
Randall J. Bateman
John C. Morria
Christoph Laske
Document Type
Journal Article
Publisher
Nature Publishing Group
Place of Publication
United Kingdom
School
School of Medical and Health Sciences
RAS ID
24691
Funders
Dominantly Inherited Alzheimer’s Network (DIAN, U19AG032438) funded by the National Institute on Aging (NIA)
German Center for Neurodegenerative Diseases (DZNE)
Abstract
The relationship between body-mass index (BMI) and Alzheimeŕs disease (AD) has been extensively investigated. However, BMI alterations in preclinical individuals with autosomal dominant AD (ADAD) have not yet been investigated. We analyzed cross-sectional data from 230 asymptomatic members of families with ADAD participating in the Dominantly Inherited Alzheimer Network (DIAN) study including 120 preclinical mutation carriers (MCs) and 110 asymptomatic non-carriers (NCs). Differences in BMI and their relation with cerebral amyloid load and episodic memory as a function of estimated years to symptom onset (EYO) were analyzed. Preclinical MCs showed significantly lower BMIs compared to NCs, starting 11.2 years before expected symptom onset. However, the BMI curves begun to diverge already at 17.8 years before expected symptom onset. Lower BMI in preclinical MCs was significantly associated with less years before estimated symptom onset, higher global Aβ brain burden, and with lower delayed total recall scores in the logical memory test. The study provides cross-sectional evidence that weight loss starts one to two decades before expected symptom onset of ADAD. Our findings point toward a link between the pathophysiology of ADAD and disturbance of weight control mechanisms. Longitudinal follow-up studies are warranted to investigate BMI changes over time.
DOI
10.1038/s41598-017-01327-w
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Comments
Müller, S., Preische, O., Sohrabi, H. R., Gräber, S., Jucker, M., Dietzsch, J., ... & Ghetti, B. (2017). Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer’s disease. Scientific Reports, 7(1), Article 1225.
https://doi.org/10.1038/s41598-017-01327-w